dc.contributor.author |
Rajapakse, Senaka |
|
dc.contributor.author |
Rodrigo, Chaturaka |
|
dc.contributor.author |
Fernando, Sumadhya Deepika |
|
dc.date.accessioned |
2021-07-30T17:54:42Z |
|
dc.date.available |
2021-07-30T17:54:42Z |
|
dc.date.issued |
2011 |
|
dc.identifier.citation |
Rajapakse, S., Rodrigo, C., & Fernando, S. D. (2011). Drug treatment of scrub typhus. Tropical doctor, 41(1), 1-4. |
en_US |
dc.identifier.uri |
http://archive.cmb.ac.lk:8080/xmlui/handle/70130/5627 |
|
dc.description.abstract |
Scrub typhus is a vector-borne disease caused by the pathogen Orientia tsutsugamushi. We review the
published literature for evidence on drug treatment in scrub typhus. Doxycycline has a proven efficacy in
several trials and a meta-analysis, although resistance has been documented in parts of northern
Thailand. Macrolides are equally efficacious and have less adverse effects, but they are expensive.
Azithromycin is the recommended drug in pregnancy and for children. Rifampicin is effective in areas
where doxycycline resistance is present. Quinolones have shown some degree of efficacy but the
evidence is scant. Most clinical evidence on drug treatment is from cases of mild-to-moderate scrub
typhus. Further study is needed on the efficacy of different antibiotics in the treatment of severe, lifethreatening scrub typhus |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
SAGE Publications |
en_US |
dc.title |
Drug treatment of scrub typhus |
en_US |
dc.type |
Article |
en_US |